These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A review of vaccine research and development: the human immunodeficiency virus (HIV). Girard MP; Osmanov SK; Kieny MP Vaccine; 2006 May; 24(19):4062-81. PubMed ID: 16530298 [TBL] [Abstract][Full Text] [Related]
4. AIDS vaccines: back to 'plan A'. Check E Nature; 2003 Jun; 423(6943):912-4. PubMed ID: 12827164 [No Abstract] [Full Text] [Related]
5. [Development of an AIDS vaccine: status report]. Girard MP Med Trop (Mars); 2007 Aug; 67(4):340-6. PubMed ID: 17926791 [TBL] [Abstract][Full Text] [Related]
6. HIV hope ride on therapeutic vaccine. AIDS Read; 2005 Jul; 15(7):332. PubMed ID: 16044573 [No Abstract] [Full Text] [Related]
7. HIV. Escape artist par excellence. Cohen J Science; 2003 Mar; 299(5612):1505-8. PubMed ID: 12624245 [No Abstract] [Full Text] [Related]
8. Steady but slow progress toward AIDS vaccine. Minn Med; 1993 Aug; 76(8):38-9. PubMed ID: 8371702 [No Abstract] [Full Text] [Related]
9. Disappointing data scuttle plans for large-scale AIDS vaccine trial. Cohen J Science; 2002 Mar; 295(5560):1616-7. PubMed ID: 11872804 [No Abstract] [Full Text] [Related]
10. Challenges and opportunities for development of an AIDS vaccine. Nabel GJ Nature; 2001 Apr; 410(6831):1002-7. PubMed ID: 11309631 [TBL] [Abstract][Full Text] [Related]
11. Correlates of immune protection and the development of a human immunodeficiency virus vaccine. Letvin NL Immunity; 2007 Sep; 27(3):366-9. PubMed ID: 17892845 [TBL] [Abstract][Full Text] [Related]
12. [AIDS vaccines: an enigma in vaccine development]. Dorner F; Barrett N Wien Klin Wochenschr; 1990 Jan; 102(2):51-8. PubMed ID: 1689919 [TBL] [Abstract][Full Text] [Related]
13. AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hope. Emini EA; Koff WC Science; 2004 Jun; 304(5679):1913-4. PubMed ID: 15218131 [No Abstract] [Full Text] [Related]
14. Fc receptor but not complement binding is important in antibody protection against HIV. Hessell AJ; Hangartner L; Hunter M; Havenith CE; Beurskens FJ; Bakker JM; Lanigan CM; Landucci G; Forthal DN; Parren PW; Marx PA; Burton DR Nature; 2007 Sep; 449(7158):101-4. PubMed ID: 17805298 [TBL] [Abstract][Full Text] [Related]
15. Honing the immune attack on HIV. Gilden D GMHC Treat Issues; 1996 Dec; 10(12):8-11. PubMed ID: 11364019 [TBL] [Abstract][Full Text] [Related]
16. Long lived multi-isotype anti-HIV antibody responses following a prime-double boost immunization strategy. Stambas J; Brown SA; Gutierrez A; Sealy R; Yue W; Jones B; Lockey TD; Zirkel A; Freiden P; Brown B; Surman S; Coleclough C; Slobod KS; Doherty PC; Hurwitz JL Vaccine; 2005 Mar; 23(19):2454-64. PubMed ID: 15752831 [TBL] [Abstract][Full Text] [Related]
17. The immune response to HIV: implications for vaccine development. Bolognesi DP Semin Immunol; 1993 Jun; 5(3):203-14. PubMed ID: 8347841 [TBL] [Abstract][Full Text] [Related]
18. HIV vaccine design and the neutralizing antibody problem. Burton DR; Desrosiers RC; Doms RW; Koff WC; Kwong PD; Moore JP; Nabel GJ; Sodroski J; Wilson IA; Wyatt RT Nat Immunol; 2004 Mar; 5(3):233-6. PubMed ID: 14985706 [No Abstract] [Full Text] [Related]